首页 > 最新文献

Biofabrication最新文献

英文 中文
Fabrication of 3D engineered intestinal tissue producing abundant mucus by air-liquid interface culture using paper-based dual-layer scaffold. 利用纸基双层支架,通过气液界面培养法制造可产生大量粘液的三维工程肠组织。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-06-17 DOI: 10.1088/1758-5090/ad504b
Mari Nagasawa, Mai Onuki, Natsuki Imoto, Kazuomi Tanaka, Ryo Tanaka, Moeka Kawada, Keiichi Imato, Kenta Iitani, Yuji Tsuchido, Naoya Takeda

Fabrication of engineered intestinal tissues with the structures and functions as humans is crucial and promising as the tools for developing drugs and functional foods. The aim of this study is to fabricate an engineered intestinal tissue from Caco-2 cells by air-liquid interface culture using a paper-based dual-layer scaffold and analyze its structure and functions. Just by simply placing on a folded paper soaked in the medium, the electrospun gelatin microfiber mesh as the upper cell adhesion layer of the dual-layer scaffold was exposed to the air, while the lower paper layer worked to preserve and supply the cell culture medium to achieve stable culture over several weeks. Unlike the flat tissue produced using the conventional commercial cultureware, Transwell, the engineered intestinal tissue fabricated in this study formed three-dimensional villous architectures. Microvilli and tight junction structures characteristic of epithelial tissue were also formed at the apical side. Furthermore, compared to the tissue prepared by Transwell, mucus production was significantly larger, and the enzymatic activities of drug metabolism and digestion were almost equivalent. In conclusion, the air-liquid interface culture using the paper-based dual-layer scaffold developed in this study was simple but effective in fabricating the engineered intestinal tissue with superior structures and functions.

作为开发药物和功能性食品的工具,制造具有与人体相同结构和功能的工程化肠道组织至关重要且前景广阔。本研究的目的是利用纸基双层支架,通过气液界面培养从Caco-2细胞中制造出工程肠组织,并分析其结构和功能。只需将浸泡在培养基中的折叠纸放在双层支架上,作为上层细胞粘附层的电纺明胶超细纤维网就会暴露在空气中,而下层纸则起到保存和供应细胞培养基的作用,从而实现数周的稳定培养。与使用传统商业培养器皿 Transwell 制作的平面组织不同,本研究制作的工程肠组织形成了三维绒毛结构。在顶端还形成了上皮组织特有的微绒毛和紧密连接结构。此外,与 Transwell 制备的组织相比,粘液的产生量明显增加,药物代谢和消化的酶活性几乎相同。总之,利用本研究开发的纸基双层支架进行气液界面培养虽然简单,但却能有效地制备出结构和功能优异的工程肠组织。
{"title":"Fabrication of 3D engineered intestinal tissue producing abundant mucus by air-liquid interface culture using paper-based dual-layer scaffold.","authors":"Mari Nagasawa, Mai Onuki, Natsuki Imoto, Kazuomi Tanaka, Ryo Tanaka, Moeka Kawada, Keiichi Imato, Kenta Iitani, Yuji Tsuchido, Naoya Takeda","doi":"10.1088/1758-5090/ad504b","DOIUrl":"10.1088/1758-5090/ad504b","url":null,"abstract":"<p><p>Fabrication of engineered intestinal tissues with the structures and functions as humans is crucial and promising as the tools for developing drugs and functional foods. The aim of this study is to fabricate an engineered intestinal tissue from Caco-2 cells by air-liquid interface culture using a paper-based dual-layer scaffold and analyze its structure and functions. Just by simply placing on a folded paper soaked in the medium, the electrospun gelatin microfiber mesh as the upper cell adhesion layer of the dual-layer scaffold was exposed to the air, while the lower paper layer worked to preserve and supply the cell culture medium to achieve stable culture over several weeks. Unlike the flat tissue produced using the conventional commercial cultureware, Transwell, the engineered intestinal tissue fabricated in this study formed three-dimensional villous architectures. Microvilli and tight junction structures characteristic of epithelial tissue were also formed at the apical side. Furthermore, compared to the tissue prepared by Transwell, mucus production was significantly larger, and the enzymatic activities of drug metabolism and digestion were almost equivalent. In conclusion, the air-liquid interface culture using the paper-based dual-layer scaffold developed in this study was simple but effective in fabricating the engineered intestinal tissue with superior structures and functions.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141093012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a biofabricated 3Din vitrovessel model for investigating transendothelial migration in stem cell therapy. 开发生物制造的三维体外血管模型,用于研究干细胞疗法中的跨内皮迁移。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-06-13 DOI: 10.1088/1758-5090/ad51a5
Mattis Wachendörfer, Alena Lisa Palkowitz, Horst Fischer

Systemic stem cell therapies hold promise for treating severe diseases, but their efficiency is hampered by limited migration of injected stem cells across vascular endothelium towards diseased tissues. Understanding transendothelial migration is crucial for improving therapy outcomes. We propose a novel 3Din vitrovessel model that aids to unravel these mechanisms and thereby facilitates stem cell therapy development. Our model simulates inflammation through cytokine diffusion from the tissue site into the vessel. It consists of a biofabricated vessel embedded in a fibrin hydrogel, mimicking arterial wall composition with smooth muscle cells and fibroblasts. The perfusable channel is lined with a functional endothelium which expresses vascular endothelial cadherin, provides an active barrier function, aligns with flow direction and is reconstructed byin situtwo-photon-microscopy. Inflammatory cytokine release (tumor necrosis factorα, stromal-derived factor (1) is demonstrated in both a transwell assay and the 3D model. In proof-of-principle experiments, mesoangioblasts, known as a promising candidate for a stem cell therapy against muscular dystrophies, are injected into the vessel model, showing shear-resistant endothelial adhesion under capillary-like flow conditions. Our 3Din vitromodel offers significant potential to study transendothelial migration mechanisms of stem cells, facilitating the development of improved stem cell therapies.

全身性干细胞疗法有望治疗严重疾病,但由于注射干细胞穿过血管内皮向病变组织迁移的能力有限,影响了治疗效率。了解跨内皮迁移对改善治疗效果至关重要。我们提出了一种新型三维体外血管模型,有助于揭示这些机制,从而促进干细胞疗法的开发。我们的模型模拟了通过细胞因子从组织部位扩散到血管的炎症。该模型由嵌入纤维蛋白水凝胶的生物制造血管组成,模拟平滑肌细胞和成纤维细胞构成的动脉壁。可灌注通道内衬有功能性内皮细胞,该内皮细胞表达血管内皮粘附素,具有主动屏障功能,与血流方向一致,并可通过原位双光子显微镜进行重建。炎症细胞因子(肿瘤坏死因子 α、基质衍生因子 1)的释放在透孔试验和三维模型中都得到了证实。在原理验证实验中,血管中胚层细胞被注入血管模型,在毛细血管样流动条件下显示出抗剪切内皮粘附性。我们的三维体外模型为研究干细胞的跨内皮迁移机制提供了巨大潜力,有助于开发更好的干细胞疗法。
{"title":"Development of a biofabricated 3D<i>in vitro</i>vessel model for investigating transendothelial migration in stem cell therapy.","authors":"Mattis Wachendörfer, Alena Lisa Palkowitz, Horst Fischer","doi":"10.1088/1758-5090/ad51a5","DOIUrl":"10.1088/1758-5090/ad51a5","url":null,"abstract":"<p><p>Systemic stem cell therapies hold promise for treating severe diseases, but their efficiency is hampered by limited migration of injected stem cells across vascular endothelium towards diseased tissues. Understanding transendothelial migration is crucial for improving therapy outcomes. We propose a novel 3D<i>in vitro</i>vessel model that aids to unravel these mechanisms and thereby facilitates stem cell therapy development. Our model simulates inflammation through cytokine diffusion from the tissue site into the vessel. It consists of a biofabricated vessel embedded in a fibrin hydrogel, mimicking arterial wall composition with smooth muscle cells and fibroblasts. The perfusable channel is lined with a functional endothelium which expresses vascular endothelial cadherin, provides an active barrier function, aligns with flow direction and is reconstructed by<i>in situ</i>two-photon-microscopy. Inflammatory cytokine release (tumor necrosis factor<i>α</i>, stromal-derived factor (1) is demonstrated in both a transwell assay and the 3D model. In proof-of-principle experiments, mesoangioblasts, known as a promising candidate for a stem cell therapy against muscular dystrophies, are injected into the vessel model, showing shear-resistant endothelial adhesion under capillary-like flow conditions. Our 3D<i>in vitro</i>model offers significant potential to study transendothelial migration mechanisms of stem cells, facilitating the development of improved stem cell therapies.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D bioprinting of dense cellular structures within hydrogels with spatially controlled heterogeneity. 在具有空间异质性控制的水凝胶中进行致密细胞结构的三维生物打印。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-06-11 DOI: 10.1088/1758-5090/ad52f1
Alperen Abaci, Murat Guvendiren

Embedded bioprinting is an emerging technology for precise deposition of cell-laden or cell-only bioinks to construct tissue like structures. Bioink is extruded or transferred into a yield stress hydrogel or a microgel support bath allowing print needle motion during printing and providing temporal support for the printed construct. Although this technology has enabled creation of complex tissue structures, it remains a challenge to develop a support bath with user-defined extracellular mimetic cues and their spatial and temporal control. This is crucial to mimic the dynamic nature of the native tissue to better regenerate tissues and organs. To address this, we present a bioprinting approach involving printing of a photocurable viscous support layer and bioprinting of a cell-only or cell-laden bioink within this viscous layer followed by brief exposure to light to partially crosslink the support layer. This approach does not require shear thinning behavior and is suitable for a wide range of photocurable hydrogels to be used as a support. It enables multi-material printing to spatially control support hydrogel heterogeneity including temporal delivery of bioactive cues (e.g. growth factors), and precise patterning of dense multi-cellular structures within these hydrogel supports. Here, dense stem cell aggregates are printed within methacrylated hyaluronic acid-based hydrogels with patterned heterogeneity to spatially modulate human mesenchymal stem cell osteogenesis. This study has significant impactions on creating tissue interfaces (e.g. osteochondral tissue) in which spatial control of extracellular matrix properties for patterned stem cell differentiation is crucial.

嵌入式生物打印是一种新兴技术,用于精确沉积含有细胞或只有细胞的生物墨水,以构建类似组织的结构。生物墨水被挤出或转移到屈服应力水凝胶或微凝胶支撑浴中,从而允许打印针在打印过程中移动,并为打印结构提供时间支持。虽然这项技术能够创建复杂的组织结构,但开发具有用户定义的细胞外模拟线索及其空间和时间控制的支撑浴仍是一项挑战。这对于模拟原生组织的动态性质以更好地再生组织和器官至关重要。为了解决这个问题,我们提出了一种生物打印方法,包括打印光固化粘性支撑层,以及在该粘性层中打印纯细胞或含有细胞的生物墨水,然后短暂暴露在光下使支撑层部分交联。这种方法不需要剪切稀化行为,适用于用作支撑层的各种光固化水凝胶。它使多材料打印技术能够在空间上控制支撑水凝胶的异质性,包括生物活性线索(如生长因子)的时间传递,以及在这些水凝胶支撑层内精确绘制致密多细胞结构的图案。在这里,致密的干细胞聚集体被印制在具有异质性图案的甲基丙烯酸透明质酸基水凝胶中,以在空间上调节人类间充质干细胞的成骨作用。这项研究对创建组织界面(如骨软骨组织)具有重要影响,在这种界面中,ECM特性的空间控制对干细胞的模式化分化至关重要。
{"title":"3D bioprinting of dense cellular structures within hydrogels with spatially controlled heterogeneity.","authors":"Alperen Abaci, Murat Guvendiren","doi":"10.1088/1758-5090/ad52f1","DOIUrl":"10.1088/1758-5090/ad52f1","url":null,"abstract":"<p><p>Embedded bioprinting is an emerging technology for precise deposition of cell-laden or cell-only bioinks to construct tissue like structures. Bioink is extruded or transferred into a yield stress hydrogel or a microgel support bath allowing print needle motion during printing and providing temporal support for the printed construct. Although this technology has enabled creation of complex tissue structures, it remains a challenge to develop a support bath with user-defined extracellular mimetic cues and their spatial and temporal control. This is crucial to mimic the dynamic nature of the native tissue to better regenerate tissues and organs. To address this, we present a bioprinting approach involving printing of a photocurable viscous support layer and bioprinting of a cell-only or cell-laden bioink within this viscous layer followed by brief exposure to light to partially crosslink the support layer. This approach does not require shear thinning behavior and is suitable for a wide range of photocurable hydrogels to be used as a support. It enables multi-material printing to spatially control support hydrogel heterogeneity including temporal delivery of bioactive cues (e.g. growth factors), and precise patterning of dense multi-cellular structures within these hydrogel supports. Here, dense stem cell aggregates are printed within methacrylated hyaluronic acid-based hydrogels with patterned heterogeneity to spatially modulate human mesenchymal stem cell osteogenesis. This study has significant impactions on creating tissue interfaces (e.g. osteochondral tissue) in which spatial control of extracellular matrix properties for patterned stem cell differentiation is crucial.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141183945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation. 为高通量癌症类器官模型构建和药物评估开发三维生物打印平台。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-06-07 DOI: 10.1088/1758-5090/ad51a6
Rui Dai, Wei Chen, You Chen, Jinlong Jin, Shiwei Zhang, Changhua Zhang, Jie Liu

The evaluation of anti-tumor drugs is critical for their development and clinical guidance. Tumor organoid models are gaining increased attention due to their ability to better mimic real tumor tissues, as well as lower time and economic costs, which makes up for the shortcomings of cell lines and xenograft models. However, current tumor organoid cultures based on the Matrigel have limitations in matching with high-throughput engineering methods due to slow gelation and low mechanical strength. Here, we present a novel composite bioink for culturing colorectal cancer organoids that provides an environment close to real tissue growth conditions and exhibits excellent photocrosslinking properties for rapid gel formation. Most importantly, the tumor organoids viability in the composite bioink after printing was as high as 97%, which also kept multicellular polar structures consistent with traditional culture methods in the Matrigel. Using 3D bioprinting with this composite bioink loaded with organoids, we demonstrated the feasibility of this drug evaluation model by validating it with clinically used colorectal cancer treatment drugs. Our results suggested that the composite bioink could effectively cultivate tumor organoids using 3D bioprinting, which had the potential to replace less reliable manual operations in promoting the application of tumor organoids in drug development and clinical guidance.

抗肿瘤药物的评估对其开发和临床指导至关重要。肿瘤类器官模型能更好地模拟真实肿瘤组织,且时间成本和经济成本较低,弥补了细胞系和异种移植模型的不足,因此越来越受到关注。然而,目前基于 Matrigel 的肿瘤类器官培养物由于凝胶化速度慢、机械强度低,在与高通量工程方法匹配方面存在局限性。在这里,我们提出了一种用于培养结直肠癌器官组织的新型复合生物墨水,它能提供接近真实组织生长条件的环境,并具有优异的光交联特性,能快速形成凝胶。最重要的是,打印后肿瘤器官组织在复合生物墨水中的存活率高达 97%,而且还能在 Matrigel 中保持与传统培养方法一致的多细胞极性结构。通过使用这种装载了器官组织的复合生物墨水进行三维生物打印,我们用临床常用的结直肠癌治疗药物验证了这种药物评估模型的可行性。我们的研究结果表明,该复合生物墨水能利用三维生物打印技术有效培养肿瘤器官组织,有望取代可靠性较低的人工操作,促进肿瘤器官组织在药物研发和临床指导中的应用。
{"title":"3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation.","authors":"Rui Dai, Wei Chen, You Chen, Jinlong Jin, Shiwei Zhang, Changhua Zhang, Jie Liu","doi":"10.1088/1758-5090/ad51a6","DOIUrl":"10.1088/1758-5090/ad51a6","url":null,"abstract":"<p><p>The evaluation of anti-tumor drugs is critical for their development and clinical guidance. Tumor organoid models are gaining increased attention due to their ability to better mimic real tumor tissues, as well as lower time and economic costs, which makes up for the shortcomings of cell lines and xenograft models. However, current tumor organoid cultures based on the Matrigel have limitations in matching with high-throughput engineering methods due to slow gelation and low mechanical strength. Here, we present a novel composite bioink for culturing colorectal cancer organoids that provides an environment close to real tissue growth conditions and exhibits excellent photocrosslinking properties for rapid gel formation. Most importantly, the tumor organoids viability in the composite bioink after printing was as high as 97%, which also kept multicellular polar structures consistent with traditional culture methods in the Matrigel. Using 3D bioprinting with this composite bioink loaded with organoids, we demonstrated the feasibility of this drug evaluation model by validating it with clinically used colorectal cancer treatment drugs. Our results suggested that the composite bioink could effectively cultivate tumor organoids using 3D bioprinting, which had the potential to replace less reliable manual operations in promoting the application of tumor organoids in drug development and clinical guidance.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling. 出血性病毒性发烧的血管功能障碍:器官模型的机遇。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-06-05 DOI: 10.1088/1758-5090/ad4c0b
Evelyn Zarate-Sanchez, Steven C George, Monica L Moya, Claire Robertson

The hemorrhagic fever viruses (HFVs) cause severe or fatal infections in humans. Named after their common symptom hemorrhage, these viruses induce significant vascular dysfunction by affecting endothelial cells, altering immunity, and disrupting the clotting system. Despite advances in treatments, such as cytokine blocking therapies, disease modifying treatment for this class of pathogen remains elusive. Improved understanding of the pathogenesis of these infections could provide new avenues to treatment. While animal models and traditional 2D cell cultures have contributed insight into the mechanisms by which these pathogens affect the vasculature, these models fall short in replicatingin vivohuman vascular dynamics. The emergence of microphysiological systems (MPSs) offers promising avenues for modeling these complex interactions. These MPS or 'organ-on-chip' models present opportunities to better mimic human vascular responses and thus aid in treatment development. In this review, we explore the impact of HFV on the vasculature by causing endothelial dysfunction, blood clotting irregularities, and immune dysregulation. We highlight how existing MPS have elucidated features of HFV pathogenesis as well as discuss existing knowledge gaps and the challenges in modeling these interactions using MPS. Understanding the intricate mechanisms of vascular dysfunction caused by HFV is crucial in developing therapies not only for these infections, but also for other vasculotropic conditions like sepsis.

出血热病毒(HFV)会对人类造成严重或致命的感染。这些病毒以其常见的出血症状命名,通过影响血管内皮细胞、改变免疫力和破坏凝血系统,诱发严重的血管功能障碍。尽管细胞因子阻断疗法等治疗方法取得了进展,但针对这类病原体的疾病调节疗法仍然遥遥无期。进一步了解这些感染的发病机制可为治疗提供新途径。虽然动物模型和传统的二维细胞培养物有助于深入了解这些病原体影响血管的机制,但这些模型在复制体内人体血管动态方面存在不足。微观生理学系统(MPS)的出现为模拟这些复杂的相互作用提供了前景广阔的途径。这些 MPS 或 "芯片上器官 "模型为更好地模拟人体血管反应提供了机会,从而有助于治疗方法的开发。在这篇综述中,我们探讨了高频变异性病毒通过引起内皮功能障碍、凝血不规则和免疫失调对血管的影响。我们重点介绍了现有的 MPS 如何阐明高频变异性血管炎发病机制的特征,并讨论了现有的知识差距以及使用 MPS 对这些相互作用进行建模所面临的挑战。了解高频病毒导致血管功能障碍的复杂机制不仅对开发这些感染的疗法至关重要,而且对开发败血症等其他血管疾病的疗法也至关重要。
{"title":"Vascular dysfunction in hemorrhagic viral fevers: opportunities for organotypic modeling.","authors":"Evelyn Zarate-Sanchez, Steven C George, Monica L Moya, Claire Robertson","doi":"10.1088/1758-5090/ad4c0b","DOIUrl":"10.1088/1758-5090/ad4c0b","url":null,"abstract":"<p><p>The hemorrhagic fever viruses (HFVs) cause severe or fatal infections in humans. Named after their common symptom hemorrhage, these viruses induce significant vascular dysfunction by affecting endothelial cells, altering immunity, and disrupting the clotting system. Despite advances in treatments, such as cytokine blocking therapies, disease modifying treatment for this class of pathogen remains elusive. Improved understanding of the pathogenesis of these infections could provide new avenues to treatment. While animal models and traditional 2D cell cultures have contributed insight into the mechanisms by which these pathogens affect the vasculature, these models fall short in replicating<i>in vivo</i>human vascular dynamics. The emergence of microphysiological systems (MPSs) offers promising avenues for modeling these complex interactions. These MPS or 'organ-on-chip' models present opportunities to better mimic human vascular responses and thus aid in treatment development. In this review, we explore the impact of HFV on the vasculature by causing endothelial dysfunction, blood clotting irregularities, and immune dysregulation. We highlight how existing MPS have elucidated features of HFV pathogenesis as well as discuss existing knowledge gaps and the challenges in modeling these interactions using MPS. Understanding the intricate mechanisms of vascular dysfunction caused by HFV is crucial in developing therapies not only for these infections, but also for other vasculotropic conditions like sepsis.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140943840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Silk fibroin increases the elasticity of alginate-gelatin hydrogels and regulates cardiac cell contractile function in cardiac bioinks. 蚕丝纤维素可增加藻酸盐-明胶水凝胶的弹性,并调节心脏生物水凝胶中心脏细胞的收缩功能。
IF 8.2 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-06-04 DOI: 10.1088/1758-5090/ad4f1b
L Vettori, H A Tran, H Mahmodi, E C Filipe, K Wyllie, C Liu Chung Ming, T R Cox, J Tipper, I V Kabakova, J Rnjak-Kovacina, C Gentile

Silk fibroin (SF) is a natural protein extracted fromBombyx morisilkworm thread. From its common use in the textile industry, it emerged as a biomaterial with promising biochemical and mechanical properties for applications in the field of tissue engineering and regenerative medicine. In this study, we evaluate for the first time the effects of SF on cardiac bioink formulations containing cardiac spheroids (CSs). First, we evaluate if the SF addition plays a role in the structural and elastic properties of hydrogels containing alginate (Alg) and gelatin (Gel). Then, we test the printability and durability of bioprinted SF-containing hydrogels. Finally, we evaluate whether the addition of SF controls cell viability and function of CSs in Alg-Gel hydrogels. Our findings show that the addition of 1% (w/v) SF to Alg-Gel hydrogels makes them more elastic without affecting cell viability. However, fractional shortening (FS%) of CSs in SF-Alg-Gel hydrogels increases without affecting their contraction frequency, suggesting an improvement in contractile function in the 3D cultures. Altogether, our findings support a promising pathway to bioengineer bioinks containing SF for cardiac applications, with the ability to control mechanical and cellular features in cardiac bioinks.

蚕丝纤维素(SF)是从蚕丝中提取的一种天然蛋白质。从纺织业的普遍应用开始,它已成为一种生物材料,具有良好的生物化学和机械性能,可应用于组织工程和再生医学领域。在本研究中,我们首次评估了 SF 对含有心脏球体的心脏生物墨水配方的影响。首先,我们评估了添加 SF 是否会对含有海藻酸盐(Alg)和明胶(Gel)的水凝胶的结构和弹性特性产生影响。然后,我们测试了含有 SF 的生物打印水凝胶的可打印性和耐久性。最后,我们评估了添加 SF 是否能控制 Alg-Gel 水凝胶中心脏球体的细胞活力和功能。我们的研究结果表明,在铝凝胶水凝胶中添加 1%(w/v)的 SF 会使其更具弹性,但不会影响细胞活力。然而,SF-Alg-凝胶水凝胶中心脏球形细胞的分数缩短率(FS%)会增加,但不会影响其收缩频率,这表明三维培养物的收缩功能得到了改善。总之,我们的研究结果为含有 SF 的生物工程生物水凝胶在心脏领域的应用提供了一条前景广阔的途径,它能够控制心脏生物水凝胶的机械和细胞特征。
{"title":"Silk fibroin increases the elasticity of alginate-gelatin hydrogels and regulates cardiac cell contractile function in cardiac bioinks.","authors":"L Vettori, H A Tran, H Mahmodi, E C Filipe, K Wyllie, C Liu Chung Ming, T R Cox, J Tipper, I V Kabakova, J Rnjak-Kovacina, C Gentile","doi":"10.1088/1758-5090/ad4f1b","DOIUrl":"10.1088/1758-5090/ad4f1b","url":null,"abstract":"<p><p>Silk fibroin (SF) is a natural protein extracted from<i>Bombyx mori</i>silkworm thread. From its common use in the textile industry, it emerged as a biomaterial with promising biochemical and mechanical properties for applications in the field of tissue engineering and regenerative medicine. In this study, we evaluate for the first time the effects of SF on cardiac bioink formulations containing cardiac spheroids (CSs). First, we evaluate if the SF addition plays a role in the structural and elastic properties of hydrogels containing alginate (Alg) and gelatin (Gel). Then, we test the printability and durability of bioprinted SF-containing hydrogels. Finally, we evaluate whether the addition of SF controls cell viability and function of CSs in Alg-Gel hydrogels. Our findings show that the addition of 1% (w/v) SF to Alg-Gel hydrogels makes them more elastic without affecting cell viability. However, fractional shortening (FS%) of CSs in SF-Alg-Gel hydrogels increases without affecting their contraction frequency, suggesting an improvement in contractile function in the 3D cultures. Altogether, our findings support a promising pathway to bioengineer bioinks containing SF for cardiac applications, with the ability to control mechanical and cellular features in cardiac bioinks.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141079658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cell bank paradigm for preclinical evaluation of an analogous cellular product for an allogeneic cell therapy. 细胞库范例,用于对异体细胞疗法的类似细胞产品进行临床前评估。
IF 8.2 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-06-03 DOI: 10.1088/1758-5090/ad4de2
Rachel C Nordberg, Ryan P Donahue, M Gabriela Espinosa, Evelia Y Salinas, Jerry C Hu, Kyriacos A Athanasiou

Toward the translation of allogeneic cell therapy products, cell banks are needed not only to manufacture the final human product but also during the preclinical evaluation of an animal-based analogous cellular product (ACP). These cell banks need to be established at both the master cell bank (MCB) level and the working cell bank (WCB) level. Inasmuch as most of the development of cell therapy products is at academic centers, it is imperative that academic researchers understand how to establish MCBs and WCBs within an academic environment. To illustrate this process, using articular cartilage as the model, a cell bank for an ACP was developed (MCBs at passage 2, WCBs at passage 5) to produce self-assembled neocartilage for preclinical evaluation (constructs at passage 7). The cell bank system is estimated to be able to produce between 160 000 and 400 000 constructs for each of the six MCBs. Overall, the ACP cell bank yielded constructs that are analogous to the intended human product, which is critical toward conducting preclinical evaluations of the ACP for inclusion in an Investigational New Drug application to the FDA.

在转化异体细胞治疗产品的过程中,不仅需要细胞库来生产最终的人体产品,而且还需要在对基于动物的类似细胞产品(ACP)进行临床前评估时建立细胞库。这些细胞库需要在主细胞库(MCB)和工作细胞库(WCB)两级建立。由于细胞治疗产品的开发大多在学术中心进行,因此学术研究人员必须了解如何在学术环境中建立 MCB 和 WCB。为了说明这一过程,我们以关节软骨为模型,建立了一个 ACP 细胞库(MCB 在第 2 个阶段,WCB 在第 5 个阶段),用于生产自我组装的新软骨,以供临床前评估(构建物在第 7 个阶段)。据估计,细胞库系统可为六种 MCB 生产 160,000 到 400,000 个构建体。总之,ACP 细胞库产生的构建体与预期的人类产品相似,这对于进行 ACP 临床前评估,以便将其纳入向美国食品及药物管理局提交的新药研究申请至关重要。
{"title":"A cell bank paradigm for preclinical evaluation of an analogous cellular product for an allogeneic cell therapy.","authors":"Rachel C Nordberg, Ryan P Donahue, M Gabriela Espinosa, Evelia Y Salinas, Jerry C Hu, Kyriacos A Athanasiou","doi":"10.1088/1758-5090/ad4de2","DOIUrl":"10.1088/1758-5090/ad4de2","url":null,"abstract":"<p><p>Toward the translation of allogeneic cell therapy products, cell banks are needed not only to manufacture the final human product but also during the preclinical evaluation of an animal-based analogous cellular product (ACP). These cell banks need to be established at both the master cell bank (MCB) level and the working cell bank (WCB) level. Inasmuch as most of the development of cell therapy products is at academic centers, it is imperative that academic researchers understand how to establish MCBs and WCBs within an academic environment. To illustrate this process, using articular cartilage as the model, a cell bank for an ACP was developed (MCBs at passage 2, WCBs at passage 5) to produce self-assembled neocartilage for preclinical evaluation (constructs at passage 7). The cell bank system is estimated to be able to produce between 160 000 and 400 000 constructs for each of the six MCBs. Overall, the ACP cell bank yielded constructs that are analogous to the intended human product, which is critical toward conducting preclinical evaluations of the ACP for inclusion in an Investigational New Drug application to the FDA.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11534090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141070310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maximization of uricase production in a column bioreactor through response surface methodology-based optimization. 通过基于 RSM 的优化,最大限度地提高柱式生物反应器中尿酸酶的产量。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-05-30 DOI: 10.1088/1758-5090/ad467f
Mohammad Hossein Taghizadeh, Khosro Khajeh, Niloofar Nasirpour, Seyyed Mohammad Mousavi

Uricase (EC 1.7.3.3) is an oxidoreductase enzyme that is widely exploited for diagnostic and treatment purposes in medicine. This study focuses on producing recombinant uricase fromE. coliBL21 in a bubble column bioreactor (BCB) and finding the optimal conditions for maximum uricase activity. The three most effective variables on uricase activity were selected through the Plackett-Burman design from eight different variables and were further optimized by the central composite design of the response surface methodology (RSM). The selected variables included the inoculum size (%v/v), isopropylβ-d-1-thiogalactopyranoside (IPTG) concentration (mM) and the initial pH of the culture medium. The activity of uricase, the final optical density at 600 nm wavelength (OD600) and the final pH were considered as the responses of this optimization and were modeled. As a result, activity of 5.84 U·ml-1and a final OD600of 3.42 were obtained at optimum conditions of 3% v/v inoculum size, an IPTG concentration of 0.54 mM and a pH of 6.0. By purifying the obtained enzyme using a Ni-NTA agarose affinity chromatography column, 165 ± 1.5 mg uricase was obtained from a 600 ml cell culture. The results of this study show that BCBs can be a highly effective option for large-scale uricase production.

尿酸酶(EC 1.7.3.3)是一种氧化还原酶,被广泛用于医学诊断和治疗。本研究的重点是在气泡柱生物反应器(BCB)中从大肠杆菌 BL21 中生产重组尿酸酶,并找到使尿酸酶活性最大化的最佳条件。通过 Plackett-Burman 设计,从 8 个不同变量中选出了对尿酸酶活性最有效的三个变量,并通过 RSM 的中心复合设计进行了进一步优化。所选变量包括接种物大小(%v/v)、IPTG(异丙基β-d-1-硫代半乳糖苷)浓度(mM)和培养基初始 pH 值。尿酸酶活性、最终 OD600(600 纳米波长下的光密度)和最终 pH 值被视为此次优化的响应,并建立了模型。结果,在接种物大小为 3 %v/v、IPTG 浓度为 0.54 mM、pH=6.0 的最佳条件下,获得了 5.84 U.ml-1 的活性和 3.42 的最终 OD600。通过使用 Ni-NTA 琼脂糖亲和层析柱纯化所获得的酶,从 600 mL 细胞培养物中获得了 165±1.5 mg 尿酸酶。这项研究的结果表明,气泡柱生物反应器是大规模生产尿酸酶的一种高效选择。
{"title":"Maximization of uricase production in a column bioreactor through response surface methodology-based optimization.","authors":"Mohammad Hossein Taghizadeh, Khosro Khajeh, Niloofar Nasirpour, Seyyed Mohammad Mousavi","doi":"10.1088/1758-5090/ad467f","DOIUrl":"10.1088/1758-5090/ad467f","url":null,"abstract":"<p><p>Uricase (EC 1.7.3.3) is an oxidoreductase enzyme that is widely exploited for diagnostic and treatment purposes in medicine. This study focuses on producing recombinant uricase from<i>E. coli</i>BL21 in a bubble column bioreactor (BCB) and finding the optimal conditions for maximum uricase activity. The three most effective variables on uricase activity were selected through the Plackett-Burman design from eight different variables and were further optimized by the central composite design of the response surface methodology (RSM). The selected variables included the inoculum size (%v/v), isopropyl<i>β-d</i>-1-thiogalactopyranoside (IPTG) concentration (mM) and the initial pH of the culture medium. The activity of uricase, the final optical density at 600 nm wavelength (OD<sub>600</sub>) and the final pH were considered as the responses of this optimization and were modeled. As a result, activity of 5.84 U·ml<sup>-1</sup>and a final OD<sub>600</sub>of 3.42 were obtained at optimum conditions of 3% v/v inoculum size, an IPTG concentration of 0.54 mM and a pH of 6.0. By purifying the obtained enzyme using a Ni-NTA agarose affinity chromatography column, 165 ± 1.5 mg uricase was obtained from a 600 ml cell culture. The results of this study show that BCBs can be a highly effective option for large-scale uricase production.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pillar electrodes embedded in the skeletal muscle tissue for selective stimulation of biohybrid actuators with increased contractile distance. 嵌入骨骼肌组织的柱状电极,用于选择性刺激生物杂交致动器,增加收缩距离。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-05-28 DOI: 10.1088/1758-5090/ad4ba1
Tingyu Li, Minghao Nie, Yuya Morimoto, Shoji Takeuchi

Electrodes are crucial for controlling the movements of biohybrid robots, but their external placement outside muscle tissue often leads to inefficient and non-selective stimulation of nearby biohybrid actuators. To address this, we propose embedding pillar electrodes within the skeletal muscle tissue, resulting in enhanced contraction of the target muscle without affecting the neighbor tissue with a 4 mm distance. We use finite element method simulations to establish a selectivity model, correlating the VIE(volume integration of electric field intensity within muscle tissue) with actual contractile distances under different amplitudes of electrical pulses. The simulated selective index closely aligns with experimental results, showing the potential of pillar electrodes for effective and selective biohybrid actuator stimulation. In experiments, we validated that the contractile distance and selectivity achieved with these pillar electrodes exceed conventional Au rod electrodes. This innovation has promising implications for building biohybrid robots with densely arranged muscle tissue, ultimately achieving more human-like movements. Additionally, our selectivity model offers valuable predictive tools for assessing electrical stimulation effects with different electrode designs.

电极对于控制生物杂交机器人的运动至关重要,但将电极置于肌肉组织外往往会导致对附近生物杂交致动器的刺激效率低下且无选择性。为解决这一问题,我们建议将支柱电极嵌入骨骼肌组织内,从而增强目标肌肉的收缩,而不影响距离为 4 毫米的邻近组织。我们利用有限元法(FEM)模拟建立了一个选择性模型,将 VIE(肌肉组织内电场强度的体积积分)与不同电脉冲振幅下的实际收缩距离相关联。模拟的选择性指数与实验结果密切吻合,显示了支柱电极在有效和选择性生物杂交致动器刺激方面的潜力。在实验中,我们验证了这些柱状电极实现的收缩距离和选择性超过了传统的金棒电极。这一创新对制造具有密集排列肌肉组织的生物杂交机器人,最终实现更像人类的运动具有重要意义。此外,我们的选择性模型为评估不同电极设计的电刺激效果提供了宝贵的预测工具。
{"title":"Pillar electrodes embedded in the skeletal muscle tissue for selective stimulation of biohybrid actuators with increased contractile distance.","authors":"Tingyu Li, Minghao Nie, Yuya Morimoto, Shoji Takeuchi","doi":"10.1088/1758-5090/ad4ba1","DOIUrl":"10.1088/1758-5090/ad4ba1","url":null,"abstract":"<p><p>Electrodes are crucial for controlling the movements of biohybrid robots, but their external placement outside muscle tissue often leads to inefficient and non-selective stimulation of nearby biohybrid actuators. To address this, we propose embedding pillar electrodes within the skeletal muscle tissue, resulting in enhanced contraction of the target muscle without affecting the neighbor tissue with a 4 mm distance. We use finite element method simulations to establish a selectivity model, correlating the VI<sub>E</sub>(volume integration of electric field intensity within muscle tissue) with actual contractile distances under different amplitudes of electrical pulses. The simulated selective index closely aligns with experimental results, showing the potential of pillar electrodes for effective and selective biohybrid actuator stimulation. In experiments, we validated that the contractile distance and selectivity achieved with these pillar electrodes exceed conventional Au rod electrodes. This innovation has promising implications for building biohybrid robots with densely arranged muscle tissue, ultimately achieving more human-like movements. Additionally, our selectivity model offers valuable predictive tools for assessing electrical stimulation effects with different electrode designs.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functionally graded hydrogels with opposing biochemical cues for osteochondral tissue engineering. 用于骨软骨组织工程的具有相反生化线索的功能分级水凝胶。
IF 9 2区 医学 Q1 ENGINEERING, BIOMEDICAL Pub Date : 2024-05-28 DOI: 10.1088/1758-5090/ad467e
Aman Mahajan, Zahra Sifat Zaidi, Amit Shukla, Rakshita Saxena, Dhirendra S Katti

Osteochondral tissue (OC) repair remains a significant challenge in the field of musculoskeletal tissue engineering. OC tissue displays a gradient structure characterized by variations in both cell types and extracellular matrix components, from cartilage to the subchondral bone. These functional gradients observed in the native tissue have been replicated to engineer OC tissuein vitro. While diverse fabrication methods have been employed to create these microenvironments, emulating the natural gradients and effective regeneration of the tissue continues to present a significant challenge. In this study, we present the design and development of CMC-silk interpenetrating (IPN) hydrogel with opposing dual biochemical gradients similar to native tissue with the aim to regenerate the complete OC unit. The gradients of biochemical cues were generated using an in-house-built extrusion system. Firstly, we fabricated a hydrogel that exhibits a smooth transition of sulfated carboxymethyl cellulose (sCMC) and TGF-β1 (SCT gradient hydrogel) from the upper to the lower region of the IPN hydrogel to regenerate the cartilage layer. Secondly, a hydrogel with a hydroxyapatite (HAp) gradient (HAp gradient hydrogel) from the lower to the upper region was fabricated to facilitate the regeneration of the subchondral bone layer. Subsequently, we developed a dual biochemical gradient hydrogel with a smooth transition of sCMC + TGF-β1 and HAp gradients in opposing directions, along with a blend of both biochemical cues in the middle. The results showed that the dual biochemical gradient hydrogels with biochemical cues corresponding to the three zones (i.e. cartilage, interface and bone) of the OC tissue led to differentiation of bone-marrow-derived mesenchymal stem cells to zone-specific lineages, thereby demonstrating their efficacy in directing the fate of progenitor cells. In summary, our study provided a simple and innovative method for incorporating gradients of biochemical cues into hydrogels. The gradients of biochemical cues spatially guided the differentiation of stem cells and facilitated tissue growth, which would eventually lead to the regeneration of the entire OC tissue with a smooth transition from cartilage (soft) to bone (hard) tissues. This promising approach is translatable and has the potential to generate numerous biochemical and biophysical gradients for regeneration of other interface tissues, such as tendon-to-muscle and ligament-to-bone.

骨软骨组织(OC)修复仍是肌肉骨骼组织工程领域的一项重大挑战。骨软骨组织显示出一种梯度结构,其特征是从软骨到软骨下骨的细胞类型和细胞外基质成分的变化。原生组织中的这些功能梯度已被复制到体外骨软骨组织工程中。虽然已经采用了多种制造方法来创造这些微环境,但仿真自然梯度和组织的有效再生仍然是一项重大挑战。在本研究中,我们设计并开发了一种具有对立双生化梯度的穿透性(IPN)水凝胶,旨在再生完整的骨软骨单元。生化线索梯度是利用内部制造的挤出系统在具有更高机械强度的 CMC-Silk IPN 水凝胶中产生的。首先,我们制作了一种水凝胶,它能使 sCMC 和 TGF-β1 从 IPN 水凝胶的上部区域平滑过渡到下部区域(SCT 梯度水凝胶),目的是再生软骨层。其次,我们制作了一种从下部到上部具有 HAp 梯度的水凝胶(HAp 梯度水凝胶),以促进软骨下骨层的再生。随后,我们开发了双生化梯度水凝胶,目的是再生整个骨软骨单元。制成的水凝胶显示了 sCMC + TGF-β1 和 HAp 梯度在相反方向上的平滑过渡,以及两种生化线索在界面上的混合。结果表明,双生化梯度水凝胶的三个区(即软骨区、界面区和骨区)具有相应的生化线索,能使 BMSCs 向各自的品系分化,从而证明了其在引导祖细胞命运方面的功效。所开发的双梯度水凝胶提供的生化信号有可能促进整个骨软骨组织的生长和再生,实现从软骨(软)到骨(硬)组织的平稳过渡。总之,我们的研究提供了一种将生化信号纳入水凝胶的简单而创新的方法。这种有前途的方法可以转化,并有可能推广到其他界面组织。
{"title":"Functionally graded hydrogels with opposing biochemical cues for osteochondral tissue engineering.","authors":"Aman Mahajan, Zahra Sifat Zaidi, Amit Shukla, Rakshita Saxena, Dhirendra S Katti","doi":"10.1088/1758-5090/ad467e","DOIUrl":"10.1088/1758-5090/ad467e","url":null,"abstract":"<p><p>Osteochondral tissue (OC) repair remains a significant challenge in the field of musculoskeletal tissue engineering. OC tissue displays a gradient structure characterized by variations in both cell types and extracellular matrix components, from cartilage to the subchondral bone. These functional gradients observed in the native tissue have been replicated to engineer OC tissue<i>in vitro</i>. While diverse fabrication methods have been employed to create these microenvironments, emulating the natural gradients and effective regeneration of the tissue continues to present a significant challenge. In this study, we present the design and development of CMC-silk interpenetrating (IPN) hydrogel with opposing dual biochemical gradients similar to native tissue with the aim to regenerate the complete OC unit. The gradients of biochemical cues were generated using an in-house-built extrusion system. Firstly, we fabricated a hydrogel that exhibits a smooth transition of sulfated carboxymethyl cellulose (sCMC) and TGF-<i>β</i>1 (SCT gradient hydrogel) from the upper to the lower region of the IPN hydrogel to regenerate the cartilage layer. Secondly, a hydrogel with a hydroxyapatite (HAp) gradient (HAp gradient hydrogel) from the lower to the upper region was fabricated to facilitate the regeneration of the subchondral bone layer. Subsequently, we developed a dual biochemical gradient hydrogel with a smooth transition of sCMC + TGF-<i>β</i>1 and HAp gradients in opposing directions, along with a blend of both biochemical cues in the middle. The results showed that the dual biochemical gradient hydrogels with biochemical cues corresponding to the three zones (i.e. cartilage, interface and bone) of the OC tissue led to differentiation of bone-marrow-derived mesenchymal stem cells to zone-specific lineages, thereby demonstrating their efficacy in directing the fate of progenitor cells. In summary, our study provided a simple and innovative method for incorporating gradients of biochemical cues into hydrogels. The gradients of biochemical cues spatially guided the differentiation of stem cells and facilitated tissue growth, which would eventually lead to the regeneration of the entire OC tissue with a smooth transition from cartilage (soft) to bone (hard) tissues. This promising approach is translatable and has the potential to generate numerous biochemical and biophysical gradients for regeneration of other interface tissues, such as tendon-to-muscle and ligament-to-bone.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":9.0,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biofabrication
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1